Piramal Enterprises gets grant for pharmaceutical kit for cancer treatment with CDK and antioxidant

Discover the groundbreaking patent by Piramal Enterprises Ltd for a pharmaceutical kit combining CDK and antioxidant enzyme inhibitors to revolutionize cancer treatment. Learn more about this innovative therapy now!

Related Posts

Health Canada approves AstraZeneca-Merck’s prostate can...

Jul 15, 2023

Roche to leverage Dyno Therapeutics tech for novel gene...

Nov 1, 2024

STAT+: Pharmacies fear New Year’s financial squeeze fro...

Jan 2, 2024